Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
Dofetilide by Hyloris Pharmaceuticals for Atrial Flutter: Likelihood of Approval
Dofetilide is under clinical development by Hyloris Pharmaceuticals and currently in Phase I for Atrial Flutter. According to GlobalData, Phase...